Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations (IRDs-OSR)
Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations, Monocentric Retrospective Observational Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Maurizio Battaglia Parodi, MD
- Phone Number: 00390226433545
- Email: battagliaparodi.maurizio@hsr.it
Study Contact Backup
- Name: Lorenzo Bianco, MD
- Phone Number: MD 0039 0226433545
- Email: bianco.lorenzo@hsr.it
Study Locations
-
-
Italy
-
Milan, Italy, Italy, 20132
- IRCCS Ospedale San Raffaele
-
Contact:
- Adelaide Pina
- Phone Number: +390226433545
- Email: pina.adelaide@hsr.it
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Participant completed at least one ophthalmological and retinal imaging examination at our center.
- Clinically diagnosed with IRD, as per familiy history, clinical signs or symptoms, retinal imaging findings.
- Definitive genetic diagnosis of IRD with adequate molecular test
Exclusion Criteria:
- Affected by other retinal or optic nerve conditions potentially affecting analyses (diabetic retinopathy, glaucoma).
- History of retinotoxic medications (i.e., hydroxychloroquine, pentosan polysulfate sodium, tamoxifen, ritonavir, didanosine, MEK inhibitors) intake.
- Unclear genetic diagnosis.
- Incomplete or inadequate ophthalmological and imaging tests.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Best-corrected Visual Acuity
Time Frame: through study completion, an average of 1 year
|
Measured on measured Early Treatment Diabetic Retinopathy Study (ETDRS) charts and recorded in logMAR units
|
through study completion, an average of 1 year
|
|
Macular threshold sensitivity
Time Frame: through study completion, an average of 1 year
|
Measured in decibels using fundus- tracked MP (e.g., MAIA device) across a standard grid of 68 central loci under standardized mesopic conditions. Sensitivity deviation from age-matched normative values will also be computed |
through study completion, an average of 1 year
|
|
Total Macular volume
Time Frame: through study completion, an average of 1 year
|
Measured in mm3 on OCT scans
|
through study completion, an average of 1 year
|
|
Centra Subfield Thickness
Time Frame: through study completion, an average of 1 year
|
Measured in micron on OCT scans
|
through study completion, an average of 1 year
|
|
Preserved Ellipsoid zone area
Time Frame: through study completion, an average of 1 year
|
Measured in mm2 on OCT scans
|
through study completion, an average of 1 year
|
|
Foveal Outer Nuclear Layer thickness
Time Frame: through study completion, an average of 1 year
|
Measured in microns on OCT scans
|
through study completion, an average of 1 year
|
|
Ellipsoid zone loss area
Time Frame: through study completion, an average of 1 year
|
Measured in mm2 on OCT scans
|
through study completion, an average of 1 year
|
|
Hyperautofluorescent (Robson- Holder) ring area
Time Frame: through study completion, an average of 1 year
|
Measured in mm2 on FAF images
|
through study completion, an average of 1 year
|
|
Dereased Autofluorescence area
Time Frame: through study completion, an average of 1 year
|
Measured in mm2 on Fundus autofluorescence images
|
through study completion, an average of 1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IRDs-OSR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.